Our Blog Melanoma360

Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

  Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Sketching Her Way Through Metastatic Melanoma”
04/27/2018

Sketching Her Way Through Metastatic Melanoma

  By Alicia Rowell, Vice President, AIM at Melanoma Nearly every melanoma patient or survivor that AIM has met has a coping…
Blog - Melanoma360
, 
Survivor Stories
Featured image for “Even America’s Heroes Get Melanoma”
04/26/2018

Even America’s Heroes Get Melanoma

  Meet Army Reserve veteran Erin Ball, who served eight years, including a tour in Iraq in 2004.  She was…
Blog - Melanoma360
, 
Survivor Stories
Featured image for “In Plain English… The Excitement Surrounding Opdivo”
03/07/2018

In Plain English… The Excitement Surrounding Opdivo

So the FDA granted regular approval to nivolumab (OPDIVO, Bristol-Myers Squibb Company) for the adjuvant treatment of patients with melanoma…
Blog - Melanoma360
, 
In Plain English
Featured image for “Melanoma Does Not Define Rebecca Berger”
03/07/2018

Melanoma Does Not Define Rebecca Berger

  Rebecca Berger is a 27-year-old pediatric oncology nurse practitioner who has struggled with her own cancer.  Diagnosed with melanoma in 2013, she lives in…
Blog - Melanoma360
, 
Survivor Stories
Featured image for “How Nikki Tichy Used Facebook To Raise Money, Increase Awareness, and Honor Her Friend”
03/07/2018

How Nikki Tichy Used Facebook To Raise Money, Increase Awareness, and Honor Her Friend

The start of 2018 has not been easy for Nikki Tichy.  In January, Nikki lost her long-time friend, Darcy Newton, to melanoma.  Just…
Blog - Melanoma360
, 
Friends, Family, & Caregivers
, 
Philanthropy
Featured image for “Melanoma By The State: Minnesota”
07/03/2018

Melanoma By The State: Minnesota

  Minnesota tops Midwest in melanoma incidences Minnesota has the third highest incidence rate of melanoma in the United States, tied with New…
Blog - Melanoma360
, 
Melanoma by the State
Featured image for “Melanoma by the State: Utah”
04/27/2018

Melanoma by the State: Utah

  Utah has the unfortunate distinction of having the highest rate of melanoma in the nation—a rate more than double the national…
Blog - Melanoma360
, 
Melanoma by the State
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

  Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
Blog - Melanoma360
 | 
Melanoma Research
04/27/2018

Sketching Her Way Through Metastatic Melanoma

  By Alicia Rowell, Vice President, AIM at Melanoma Nearly every melanoma patient or survivor that AIM has met has a coping…
Featured image for “Sketching Her Way Through Metastatic Melanoma”
Blog - Melanoma360
 | 
Survivor Stories
04/26/2018

Even America’s Heroes Get Melanoma

  Meet Army Reserve veteran Erin Ball, who served eight years, including a tour in Iraq in 2004.  She was…
Featured image for “Even America’s Heroes Get Melanoma”
Blog - Melanoma360
 | 
Survivor Stories
03/07/2018

In Plain English… The Excitement Surrounding Opdivo

So the FDA granted regular approval to nivolumab (OPDIVO, Bristol-Myers Squibb Company) for the adjuvant treatment of patients with melanoma…
Featured image for “In Plain English… The Excitement Surrounding Opdivo”
Blog - Melanoma360
 | 
In Plain English
03/07/2018

Melanoma Does Not Define Rebecca Berger

  Rebecca Berger is a 27-year-old pediatric oncology nurse practitioner who has struggled with her own cancer.  Diagnosed with melanoma in 2013, she lives in…
Featured image for “Melanoma Does Not Define Rebecca Berger”
Blog - Melanoma360
 | 
Survivor Stories
03/07/2018

How Nikki Tichy Used Facebook To Raise Money, Increase Awareness, and Honor Her Friend

The start of 2018 has not been easy for Nikki Tichy.  In January, Nikki lost her long-time friend, Darcy Newton, to melanoma.  Just…
Featured image for “How Nikki Tichy Used Facebook To Raise Money, Increase Awareness, and Honor Her Friend”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
07/03/2018

Melanoma By The State: Minnesota

  Minnesota tops Midwest in melanoma incidences Minnesota has the third highest incidence rate of melanoma in the United States, tied with New…
Featured image for “Melanoma By The State: Minnesota”
Blog - Melanoma360
 | 
Melanoma by the State
04/27/2018

Melanoma by the State: Utah

  Utah has the unfortunate distinction of having the highest rate of melanoma in the nation—a rate more than double the national…
Featured image for “Melanoma by the State: Utah”
Blog - Melanoma360
 | 
Melanoma by the State

Recent Posts

Featured image for “Replimune Announces BLA Acceptance and Priority Review for RP1 for the Treatment in Advanced Melanoma”
Jan. 21, 2025

Replimune Announces BLA Acceptance and Priority Review for RP1 for the Treatment in Advanced Melanoma

Featured image for “Meaning-Centered Psychotherapy: Finding Purpose in the Face of Cancer”
Jan. 14, 2025

Meaning-Centered Psychotherapy: Finding Purpose in the Face of Cancer

Featured image for “What Inspires Leading Melanoma Researchers? ”
Jan. 09, 2025

What Inspires Leading Melanoma Researchers? 

Featured image for “Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients”
Dec. 30, 2024

Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients

Featured image for “Bristol Myers Squibb Announces Approval for Subcutaneous Nivolumab”
Dec. 27, 2024

Bristol Myers Squibb Announces Approval for Subcutaneous Nivolumab

Filter by Tag